Display as
39 items found
Webinars • 08/24/2022
Conference Presentations • 08/20/2024
Trainings • 01/15/2025
Conference Presentations • 08/20/2024
Documents • 05/29/2023
Conference Presentations • 08/23/2022
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024

Replication Resources • 12/12/2024
Conference Presentations • 08/23/2022
Conference Presentations • 08/12/2020
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024
Webinars • 03/24/2023
Conference Presentations • 08/23/2022

Webinars • 08/24/2022
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024
Conference Presentations • 08/23/2022
Conference Presentations • 08/20/2024

Replication Resources • 12/12/2024
Conference Presentations • 08/23/2022
Conference Presentations • 08/12/2020
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024
Conference Presentations • 08/20/2024

Documents • 12/22/2022
Conference Presentations • 08/23/2022

Webinars • 08/24/2022
Review of the efficacy of LAIs and implementation activities undertaken by agencies.
Conference Presentations • 08/20/2024
Two sessions describing promising strategies for offering LAI in RWHAP clinics. The SPNS ALAI UP project includes a focus on equity in designing and implementing LAI programs.
Conference Presentations • 08/20/2024
Implementation of long-acting antiretroviral therapy at various sites.

Trainings • 01/15/2025
Email-based continuing education course developed by the Southeast AETC in collaboration with the ALAI-UP project.
Conference Presentations • 08/20/2024
Long-Acting Injectable Antiretroviral Therapy project's process of developing new clinical performance measures and a methodology to collect and report these data.

Documents • 05/29/2023
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.
Conference Presentations • 08/23/2022
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Conference Presentations • 08/20/2024
Two RWHAP clinics describe their approaches to providing long-acting injectable antiretroviral therapy.
Conference Presentations • 08/20/2024
Strategies for educating all people with HIV about the availability of long-acting injectable (LAI) antiretroviral therapies (ART).

Replication Resources • 12/12/2024
This playbook is intended to help EHE jurisdictions consider what they can do to enhance the implementation of long-acting injectables (LAI) for ART.
Conference Presentations • 08/23/2022
Description of an implementation science project to facilitate equitable access to benefits from LAI ART options.
Conference Presentations • 08/12/2020
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approva
Conference Presentations • 08/20/2024
Florida ADAP's pathway to coverage of long-acting Injectable therapy. Barriers addressed include patient adherence, staff training, transportation, costs, and billing.
Conference Presentations • 08/20/2024
Strategies for implementing a long-acting injectable program.
Conference Presentations • 08/20/2024
Experiences in implementing long-acting cabotegravir plus rilpivirine (LA-CAB/RPV) at a RWHAP-funded clinic within an academic health system and challenges translating into the pediatric clinic.

Webinars • 03/24/2023
Review of types of injectable long lasting HIV prevention and treatment medications and their similarities and differences.

Documents • 12/22/2022
Fact sheet on the different coverage and cost-sharing considerations for LAI ART across public and private payers.
Conference Presentations • 08/23/2022
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.